Meiji Seika and Eisai announce submission of manufacturing and marketing approval application in Japan for safinamide in Parkinson’s disease

Newron Pharmaceuticals Announces Prominent Medical Experts to Present at its 2018 R&D Day on October 31 in New York

Newron Dedicates Efforts to Research and Advocacy During Rett Awareness Month in October

Newron Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference in New York

Newron reports half-year 2018 results

Newron Pharmaceuticals will host its 2018 R&D Day on October 31 in New York City

Newron Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference

Newron provides update on STARS clinical study with sarizotan for the treatment of Rett syndrome

Newron Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference

Newron Pharmaceuticals to Present at the UBS Global Healthcare Conference 2018

Pagination